ID   KCND3_HUMAN             Reviewed;         655 AA.
AC   Q9UK17; O60576; O60577; Q14D71; Q5T0M0; Q9UH85; Q9UH86; Q9UK16;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   07-APR-2021, entry version 190.
DE   RecName: Full=Potassium voltage-gated channel subfamily D member 3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4.3;
GN   Name=KCND3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RC   TISSUE=Heart;
RX   PubMed=9843794; DOI=10.1152/ajpheart.1998.275.6.h1963;
RA   Kong W., Po S., Yamagishi T., Ashen M.D., Stetten G., Tomaselli G.F.;
RT   "Isolation and characterization of the human gene encoding Ito: further
RT   diversity by alternative mRNA splicing.";
RL   Am. J. Physiol. 275:H1963-H1970(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain, and Heart;
RX   PubMed=10200233; DOI=10.1152/jn.1999.81.4.1974;
RA   Dilks D., Ling H.-P., Cockett M., Sokol P., Numann R.;
RT   "Cloning and expression of the human Kv4.3 potassium channel.";
RL   J. Neurophysiol. 81:1974-1977(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RA   Calmels T.P.G., Faivre J.-F., Javre J.-L., Cheval B., Rouanet S., Bril A.;
RT   "Long and short human isoforms of the Kv4.3 channel: cloning, expression,
RT   electrophysiology, pharmacology and phosphorylation by protein kinase C.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=10729221; DOI=10.1006/geno.2000.6117;
RA   Isbrandt D., Leicher T., Waldschuetz R., Zhu X.-R., Luhmann U., Michel U.,
RA   Sauter K., Pongs O.;
RT   "Gene structures and expression profiles of three human KCND (Kv4)
RT   potassium channels mediating A-type currents I(TO) and I(SA).";
RL   Genomics 64:144-154(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH KCNIP2; KCNE1; KCNE2; SCN1B AND KCNAB1.
RX   PubMed=12297301; DOI=10.1016/s0014-5793(02)03296-9;
RA   Deschenes I., Tomaselli G.F.;
RT   "Modulation of Kv4.3 current by accessory subunits.";
RL   FEBS Lett. 528:183-188(2002).
RN   [9]
RP   INTERACTION WITH DLG1.
RX   PubMed=19213956; DOI=10.1161/circresaha.108.191007;
RA   El-Haou S., Balse E., Neyroud N., Dilanian G., Gavillet B., Abriel H.,
RA   Coulombe A., Jeromin A., Hatem S.N.;
RT   "Kv4 potassium channels form a tripartite complex with the anchoring
RT   protein SAP97 and CaMKII in cardiac myocytes.";
RL   Circ. Res. 104:758-769(2009).
RN   [10]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 PHE-450 AND ARG-600, AND
RP   CHARACTERIZATION OF VARIANT BRGDA9 PHE-450.
RX   PubMed=21349352; DOI=10.1016/j.hrthm.2011.02.021;
RA   Giudicessi J.R., Ye D., Tester D.J., Crotti L., Mugione A.,
RA   Nesterenko V.V., Albertson R.M., Antzelevitch C., Schwartz P.J.,
RA   Ackerman M.J.;
RT   "Transient outward current (I(to)) gain-of-function mutations in the KCND3-
RT   encoded Kv4.3 potassium channel and Brugada syndrome.";
RL   Heart Rhythm 8:1024-1032(2011).
RN   [11]
RP   INVOLVEMENT IN BRGDA9, VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600, AND
RP   CHARACTERIZATION OF VARIANTS BRGDA9 ILE-392; ARG-530 AND ARG-600.
RX   PubMed=22457051; DOI=10.1002/humu.22058;
RA   Giudicessi J.R., Ye D., Kritzberger C.J., Nesterenko V.V., Tester D.J.,
RA   Antzelevitch C., Ackerman M.J.;
RT   "Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with
RT   autopsy-negative sudden unexplained death.";
RL   Hum. Mutat. 33:989-997(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 29-143, AND INTERACTION WITH
RP   KCNIP1.
RX   PubMed=14980207; DOI=10.1016/s0896-6273(04)00049-2;
RA   Scannevin R.H., Wang K., Jow F., Megules J., Kopsco D.C., Edris W.,
RA   Carroll K.C., Lu Q., Xu W., Xu Z., Katz A.H., Olland S., Lin L., Taylor M.,
RA   Stahl M., Malakian K., Somers W., Mosyak L., Bowlby M.R., Chanda P.,
RA   Rhodes K.J.;
RT   "Two N-terminal domains of Kv4 K(+) channels regulate binding to and
RT   modulation by KChIP1.";
RL   Neuron 41:587-598(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 6-145 IN COMPLEX WITH KCNIP1, AND
RP   SUBUNIT.
RX   PubMed=17187064; DOI=10.1038/nn1822;
RA   Wang H., Yan Y., Liu Q., Huang Y., Shen Y., Chen L., Chen Y., Yang Q.,
RA   Hao Q., Wang K., Chai J.;
RT   "Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP
RT   subunits.";
RL   Nat. Neurosci. 10:32-39(2007).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-94.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANTS SCA19 PHE-227 DEL; GLU-338; VAL-345 AND MET-377, AND
RP   CHARACTERIZATION OF VARIANT PHE-227 DEL.
RX   PubMed=23280837; DOI=10.1002/ana.23701;
RA   Lee Y.C., Durr A., Majczenko K., Huang Y.H., Liu Y.C., Lien C.C.,
RA   Tsai P.C., Ichikawa Y., Goto J., Monin M.L., Li J.Z., Chung M.Y.,
RA   Mundwiller E., Shakkottai V., Liu T.T., Tesson C., Lu Y.C., Brice A.,
RA   Tsuji S., Burmeister M., Stevanin G., Soong B.W.;
RT   "Mutations in KCND3 cause spinocerebellar ataxia type 22.";
RL   Ann. Neurol. 72:859-869(2012).
RN   [16]
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390, AND CHARACTERIZATION OF
RP   VARIANTS SCA19 PRO-352; ILE-373 AND ASN-390.
RX   PubMed=23280838; DOI=10.1002/ana.23700;
RA   Duarri A., Jezierska J., Fokkens M., Meijer M., Schelhaas H.J.,
RA   den Dunnen W.F., van Dijk F., Verschuuren-Bemelmans C., Hageman G.,
RA   van de Vlies P., Kusters B., van de Warrenburg B.P., Kremer B.,
RA   Wijmenga C., Sinke R.J., Swertz M.A., Kampinga H.H., Boddeke E.,
RA   Verbeek D.S.;
RT   "Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type
RT   19.";
RL   Ann. Neurol. 72:870-880(2012).
RN   [17]
RP   VARIANT SCA19 SER-384.
RX   PubMed=28895081; DOI=10.1007/s12311-017-0883-4;
RA   Kurihara M., Ishiura H., Sasaki T., Otsuka J., Hayashi T., Terao Y.,
RA   Matsukawa T., Mitsui J., Kaneko J., Nishiyama K., Doi K., Yoshimura J.,
RA   Morishita S., Shimizu J., Tsuji S.;
RT   "Novel de novo KCND3 mutation in a Japanese patient with intellectual
RT   disability, cerebellar ataxia, myoclonus, and dystonia.";
RL   Cerebellum 17:237-242(2018).
CC   -!- FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly
CC       inactivating A-type potassium channels. May contribute to I(To) current
CC       in heart and I(Sa) current in neurons. Channel properties are modulated
CC       by interactions with other alpha subunits and with regulatory subunits.
CC       {ECO:0000269|PubMed:10200233, ECO:0000269|PubMed:9843794}.
CC   -!- SUBUNIT: Homotetramer or heterotetramer with KCND1 and/or KCND2.
CC       Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and
CC       KCNIP4 (By similarity). Interacts with KCNE1, KCNE2, SCN1B and KCNAB1
CC       and DLG1. {ECO:0000250, ECO:0000269|PubMed:12297301,
CC       ECO:0000269|PubMed:14980207, ECO:0000269|PubMed:17187064,
CC       ECO:0000269|PubMed:19213956}.
CC   -!- INTERACTION:
CC       Q9UK17; Q9NZI2: KCNIP1; NbExp=3; IntAct=EBI-9825212, EBI-2120635;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q62897};
CC       Multi-pass membrane protein {ECO:0000255}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:Q62897}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q62897}. Note=Interaction with palmitoylated
CC       KCNIP2 and KCNIP3 enhances cell surface expression.
CC       {ECO:0000250|UniProtKB:Q62897}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=KCND3L, Long;
CC         IsoId=Q9UK17-1; Sequence=Displayed;
CC       Name=2; Synonyms=KCND3S, Short;
CC         IsoId=Q9UK17-2; Sequence=VSP_008826;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain, in particular
CC       in cortex, cerebellum, amygdala and caudate nucleus. Detected at lower
CC       levels in liver, skeletal muscle, kidney and pancreas. Isoform 1
CC       predominates in most tissues. Isoform 1 and isoform 2 are detected at
CC       similar levels in brain, skeletal muscle and pancreas.
CC       {ECO:0000269|PubMed:10200233, ECO:0000269|PubMed:10729221,
CC       ECO:0000269|PubMed:9843794}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position.
CC   -!- PTM: Regulated through phosphorylation at Ser-569 by CaMK2D.
CC       {ECO:0000250}.
CC   -!- DISEASE: Spinocerebellar ataxia 19 (SCA19) [MIM:607346]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive incoordination
CC       of gait and often poor coordination of hands, speech and eye movements,
CC       due to degeneration of the cerebellum with variable involvement of the
CC       brainstem and spinal cord. SCA19 is a relatively mild, cerebellar
CC       ataxic syndrome with cognitive impairment, pyramidal tract involvement,
CC       tremor and peripheral neuropathy, and mild atrophy of the cerebellar
CC       hemispheres and vermis. {ECO:0000269|PubMed:23280837,
CC       ECO:0000269|PubMed:23280838, ECO:0000269|PubMed:28895081}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Brugada syndrome 9 (BRGDA9) [MIM:616399]: A tachyarrhythmia
CC       characterized by right bundle branch block and ST segment elevation on
CC       an electrocardiogram (ECG). It can cause the ventricles to beat so fast
CC       that the blood is prevented from circulating efficiently in the body.
CC       When this situation occurs, the individual will faint and may die in a
CC       few minutes if the heart is not reset. {ECO:0000269|PubMed:21349352,
CC       ECO:0000269|PubMed:22457051}. Note=The gene represented in this entry
CC       may be involved in disease pathogenesis.
CC   -!- SIMILARITY: Belongs to the potassium channel family. D (Shal) (TC
CC       1.A.1.2) subfamily. Kv4.3/KCND3 sub-subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Potassium voltage-gated channel, Shal-related
CC       subfamily, member 3 (KCND3); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/KCND3";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF048712; AAC05121.1; -; mRNA.
DR   EMBL; AF048713; AAC05122.1; -; mRNA.
DR   EMBL; AF187963; AAF01044.1; -; mRNA.
DR   EMBL; AF187964; AAF01045.1; -; mRNA.
DR   EMBL; AF205856; AAF20924.1; -; mRNA.
DR   EMBL; AF205857; AAF20925.1; -; mRNA.
DR   EMBL; AF120491; AAD38898.1; -; mRNA.
DR   EMBL; AF166011; AAF68177.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68177.1; JOINED; Genomic_DNA.
DR   EMBL; AF166011; AAF68178.1; -; Genomic_DNA.
DR   EMBL; AF166009; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AF166010; AAF68178.1; JOINED; Genomic_DNA.
DR   EMBL; AL512665; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL450997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL049557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56511.1; -; Genomic_DNA.
DR   EMBL; BC113475; AAI13476.1; -; mRNA.
DR   EMBL; BC113477; AAI13478.1; -; mRNA.
DR   CCDS; CCDS843.1; -. [Q9UK17-1]
DR   CCDS; CCDS844.1; -. [Q9UK17-2]
DR   RefSeq; NP_004971.2; NM_004980.4. [Q9UK17-1]
DR   RefSeq; NP_751948.1; NM_172198.2. [Q9UK17-2]
DR   RefSeq; XP_005270908.1; XM_005270851.4.
DR   RefSeq; XP_006710692.1; XM_006710629.3. [Q9UK17-1]
DR   RefSeq; XP_006710693.1; XM_006710630.3.
DR   RefSeq; XP_016856733.1; XM_017001244.1. [Q9UK17-1]
DR   PDB; 1S1G; X-ray; 2.60 A; A/B=29-143.
DR   PDB; 2NZ0; X-ray; 3.20 A; B/D=6-145.
DR   PDBsum; 1S1G; -.
DR   PDBsum; 2NZ0; -.
DR   SMR; Q9UK17; -.
DR   BioGRID; 109954; 42.
DR   ComplexPortal; CPX-3256; Kv4.3-KChIP1 channel complex.
DR   CORUM; Q9UK17; -.
DR   IntAct; Q9UK17; 2.
DR   STRING; 9606.ENSP00000319591; -.
DR   BindingDB; Q9UK17; -.
DR   ChEMBL; CHEMBL1964; -.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB00280; Disopyramide.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB11633; Isavuconazole.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB06217; Vernakalant.
DR   DrugCentral; Q9UK17; -.
DR   TCDB; 1.A.1.2.19; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q9UK17; -.
DR   PhosphoSitePlus; Q9UK17; -.
DR   BioMuta; KCND3; -.
DR   DMDM; 92090984; -.
DR   MassIVE; Q9UK17; -.
DR   PaxDb; Q9UK17; -.
DR   PeptideAtlas; Q9UK17; -.
DR   PRIDE; Q9UK17; -.
DR   ProteomicsDB; 84705; -. [Q9UK17-1]
DR   ProteomicsDB; 84706; -. [Q9UK17-2]
DR   ABCD; Q9UK17; 2 sequenced antibodies.
DR   Antibodypedia; 20128; 217 antibodies.
DR   DNASU; 3752; -.
DR   Ensembl; ENST00000302127; ENSP00000306923; ENSG00000171385. [Q9UK17-1]
DR   Ensembl; ENST00000315987; ENSP00000319591; ENSG00000171385. [Q9UK17-1]
DR   Ensembl; ENST00000369697; ENSP00000358711; ENSG00000171385. [Q9UK17-2]
DR   GeneID; 3752; -.
DR   KEGG; hsa:3752; -.
DR   UCSC; uc001ebu.2; human. [Q9UK17-1]
DR   CTD; 3752; -.
DR   DisGeNET; 3752; -.
DR   GeneCards; KCND3; -.
DR   GeneReviews; KCND3; -.
DR   HGNC; HGNC:6239; KCND3.
DR   HPA; ENSG00000171385; Tissue enhanced (brain).
DR   MalaCards; KCND3; -.
DR   MIM; 605411; gene.
DR   MIM; 607346; phenotype.
DR   MIM; 616399; phenotype.
DR   neXtProt; NX_Q9UK17; -.
DR   OpenTargets; ENSG00000171385; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 98772; Spinocerebellar ataxia type 19/22.
DR   PharmGKB; PA210; -.
DR   VEuPathDB; HostDB:ENSG00000171385.9; -.
DR   eggNOG; KOG4390; Eukaryota.
DR   GeneTree; ENSGT00940000155343; -.
DR   HOGENOM; CLU_011722_9_1_1; -.
DR   InParanoid; Q9UK17; -.
DR   OMA; RPNCKAA; -.
DR   OrthoDB; 469107at2759; -.
DR   PhylomeDB; Q9UK17; -.
DR   TreeFam; TF313103; -.
DR   PathwayCommons; Q9UK17; -.
DR   Reactome; R-HSA-1296072; Voltage gated Potassium channels.
DR   Reactome; R-HSA-5576894; Phase 1 - inactivation of fast Na+ channels.
DR   BioGRID-ORCS; 3752; 17 hits in 986 CRISPR screens.
DR   ChiTaRS; KCND3; human.
DR   EvolutionaryTrace; Q9UK17; -.
DR   GeneWiki; KCND3; -.
DR   GenomeRNAi; 3752; -.
DR   Pharos; Q9UK17; Tclin.
DR   PRO; PR:Q9UK17; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UK17; protein.
DR   Bgee; ENSG00000171385; Expressed in cerebellum and 223 other tissues.
DR   ExpressionAtlas; Q9UK17; baseline and differential.
DR   Genevisible; Q9UK17; HS.
DR   GO; GO:0043197; C:dendritic spine; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IBA:GO_Central.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0005250; F:A-type (transient outward) potassium channel activity; TAS:ProtInc.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; TAS:BHF-UCL.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IEA:GOC.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0099625; P:ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   Gene3D; 1.20.120.350; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003975; K_chnl_volt-dep_Kv4.
DR   InterPro; IPR004056; K_chnl_volt-dep_Kv4.3.
DR   InterPro; IPR024587; K_chnl_volt-dep_Kv4_C.
DR   InterPro; IPR021645; Shal-type_N.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF11879; DUF3399; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11601; Shal-type; 1.
DR   PRINTS; PR01518; KV43CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01497; SHALCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Brugada syndrome; Cell membrane;
KW   Cell projection; Disease variant; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Neurodegeneration; Phosphoprotein; Potassium;
KW   Potassium channel; Potassium transport; Reference proteome;
KW   Spinocerebellar ataxia; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel; Zinc.
FT   CHAIN           1..655
FT                   /note="Potassium voltage-gated channel subfamily D member
FT                   3"
FT                   /id="PRO_0000054068"
FT   TOPO_DOM        1..181
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        182..202
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        222..242
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        243..256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        287..307
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        308..320
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        321..341
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        360..380
FT                   /note="Pore-forming; Name=Segment H5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..402
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        403..655
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          2..20
FT                   /note="Interaction with KCNIP2"
FT                   /evidence="ECO:0000250"
FT   REGION          472..487
FT                   /note="Mediates dendritic targeting"
FT                   /evidence="ECO:0000250"
FT   MOTIF           367..372
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250"
FT   METAL           104
FT                   /note="Zinc"
FT   METAL           131
FT                   /note="Zinc"
FT   METAL           132
FT                   /note="Zinc"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0V1"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0V1"
FT   MOD_RES         569
FT                   /note="Phosphoserine; by CaMK2D"
FT                   /evidence="ECO:0000250|UniProtKB:Q62897"
FT   MOD_RES         585
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0V1"
FT   VAR_SEQ         488..506
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10200233,
FT                   ECO:0000303|PubMed:10729221, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9843794"
FT                   /id="VSP_008826"
FT   VARIANT         94
FT                   /note="V -> M (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1349469134)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035775"
FT   VARIANT         227
FT                   /note="Missing (in SCA19; results in reduced channel
FT                   activity consistent with impaired cell surface expression
FT                   of the mutant protein)"
FT                   /evidence="ECO:0000269|PubMed:23280837"
FT                   /id="VAR_070785"
FT   VARIANT         338
FT                   /note="V -> E (in SCA19)"
FT                   /evidence="ECO:0000269|PubMed:23280837"
FT                   /id="VAR_070786"
FT   VARIANT         345
FT                   /note="G -> V (in SCA19; dbSNP:rs797045634)"
FT                   /evidence="ECO:0000269|PubMed:23280837"
FT                   /id="VAR_070787"
FT   VARIANT         352
FT                   /note="T -> P (in SCA19; loss of channel activity;
FT                   dbSNP:rs397515476)"
FT                   /evidence="ECO:0000269|PubMed:23280838"
FT                   /id="VAR_070788"
FT   VARIANT         373
FT                   /note="M -> I (in SCA19; unknown pathological significance;
FT                   causes reduced channel activity; dbSNP:rs397515477)"
FT                   /evidence="ECO:0000269|PubMed:23280838"
FT                   /id="VAR_070789"
FT   VARIANT         377
FT                   /note="T -> M (in SCA19)"
FT                   /evidence="ECO:0000269|PubMed:23280837"
FT                   /id="VAR_070790"
FT   VARIANT         384
FT                   /note="G -> S (in SCA19)"
FT                   /evidence="ECO:0000269|PubMed:28895081"
FT                   /id="VAR_079709"
FT   VARIANT         390
FT                   /note="S -> N (in SCA19; unknown pathological significance;
FT                   results in impaired cell surface expression;
FT                   dbSNP:rs397515478)"
FT                   /evidence="ECO:0000269|PubMed:23280838"
FT                   /id="VAR_070791"
FT   VARIANT         392
FT                   /note="V -> I (in BRGDA9; unknown pathological
FT                   significance; gain of function mutation;
FT                   dbSNP:rs786205867)"
FT                   /evidence="ECO:0000269|PubMed:22457051"
FT                   /id="VAR_067694"
FT   VARIANT         450
FT                   /note="L -> F (in BRGDA9; unknown pathological
FT                   significance; gain of function mutation;
FT                   dbSNP:rs150401343)"
FT                   /evidence="ECO:0000269|PubMed:21349352"
FT                   /id="VAR_073831"
FT   VARIANT         530
FT                   /note="S -> R (in BRGDA9; unknown pathological
FT                   significance; does not affect the electrophysiological
FT                   properties of the channel)"
FT                   /evidence="ECO:0000269|PubMed:22457051"
FT                   /id="VAR_067695"
FT   VARIANT         600
FT                   /note="G -> R (in BRGDA9; unknown pathological
FT                   significance; gain of function mutation;
FT                   dbSNP:rs149344567)"
FT                   /evidence="ECO:0000269|PubMed:21349352,
FT                   ECO:0000269|PubMed:22457051"
FT                   /id="VAR_067696"
FT   CONFLICT        239
FT                   /note="V -> G (in Ref. 1; AAC05121/AAC05122 and 4;
FT                   AAD38898)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        375
FT                   /note="P -> L (in Ref. 1; AAC05121/AAC05122 and 4;
FT                   AAD38898)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        408
FT                   /note="R -> G (in Ref. 2; AAF01044/AAF01045)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        452
FT                   /note="E -> G (in Ref. 2; AAF01044/AAF01045)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="T -> Q (in Ref. 2; AAF01044/AAF01045)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        564
FT                   /note="A -> D (in Ref. 2; AAF01044/AAF01045)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        646
FT                   /note="A -> T (in Ref. 1; AAC05121/AAC05122, 2; AAF01045
FT                   and 4; AAD38898)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        654
FT                   /note="A -> V (in Ref. 1; AAC05121/AAC05122, 2; AAF01044
FT                   and 4; AAD38898)"
FT                   /evidence="ECO:0000305"
FT   HELIX           9..14
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   TURN            15..19
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   STRAND          20..23
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   HELIX           32..34
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   STRAND          41..46
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   STRAND          49..54
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   HELIX           55..58
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   TURN            65..67
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   HELIX           70..73
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   STRAND          74..76
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   STRAND          77..79
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   STRAND          81..84
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   HELIX           88..100
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   STRAND          101..103
FT                   /evidence="ECO:0007744|PDB:2NZ0"
FT   HELIX           111..120
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   HELIX           125..127
FT                   /evidence="ECO:0007744|PDB:1S1G"
FT   HELIX           130..144
FT                   /evidence="ECO:0007744|PDB:1S1G"
SQ   SEQUENCE   655 AA;  73451 MW;  ADD1402A97204764 CRC64;
     MAAGVAAWLP FARAAAIGWM PVANCPMPLA PADKNKRQDE LIVLNVSGRR FQTWRTTLER
     YPDTLLGSTE KEFFFNEDTK EYFFDRDPEV FRCVLNFYRT GKLHYPRYEC ISAYDDELAF
     YGILPEIIGD CCYEEYKDRK RENAERLMDD NDSENNQESM PSLSFRQTMW RAFENPHTST
     LALVFYYVTG FFIAVSVITN VVETVPCGTV PGSKELPCGE RYSVAFFCLD TACVMIFTVE
     YLLRLFAAPS RYRFIRSVMS IIDVVAIMPY YIGLVMTNNE DVSGAFVTLR VFRVFRIFKF
     SRHSQGLRIL GYTLKSCASE LGFLLFSLTM AIIIFATVMF YAEKGSSASK FTSIPASFWY
     TIVTMTTLGY GDMVPKTIAG KIFGSICSLS GVLVIALPVP VIVSNFSRIY HQNQRADKRR
     AQKKARLARI RVAKTGSSNA YLHSKRNGLL NEALELTGTP EEEHMGKTTS LIESQHHHLL
     HCLEKTTGLS YLVDDPLLSV RTSTIKNHEF IDEQMFEQNC MESSMQNYPS TRSPSLSSHP
     GLTTTCCSRR SKKTTHLPNS NLPATRLRSM QELSTIHIQG SEQPSLTTSR SSLNLKADDG
     LRPNCKTSQI TTAIISIPTP PALTPEGESR PPPASPGPNT NIPSIASNVV KVSAL
//
